Diabetes cause microvascular damage which reduce pancreatic volume, inducing pancreatic fibrosis. According to the National Institutes of Health, those afflicted by type 1 diabetes have a 30 to 50% chance of developing exocrine pancreatic insufficiency, while those with type 2 have a 20 to 30% chance of developing the disorder. Thus, the exocrine pancreatic insufficiency therapeutics market stands to gain as a result.
According the new Fortune Business Insights report, titled “Exocrine Pancreatic Insufficiency Therapeutics Market Size, Share & Industry Analysis, By Therapy (Pancreatic Enzyme Replacement Therapy (PERT), Nutritional Therapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Others) and Regional Forecast, 2019-2026”, the value of the market stood at USD 1.49 billion in 2018 and to reach reach USD 2.55 billion by 2026, exhibiting a CAGR of 6.5% during the forecast period.
See the detailed report:
Our primary research respondents typically include:
Executives working with leading companies in the market under reviewProduct/brand/marketing managersCXO level executivesRegional/zonal/ country managersVice President level executives.
Key Industry Players:
AzurRxAbbVie Inc.CHIESI Farmaceutici S.p.A.AllerganJanssen Pharmaceuticals, Inc.
To get more information on the regional analysis of this market, Request a Free sample:
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
Key Opinion Leaders associated with Infinium Global ResearchInternal and External subject matter expertsProfessionals and participants from the industry
TOC:
IntroductionResearch ScopeMarket SegmentationResearch MethodologyDefinitions and AssumptionsExecutive SummaryMarket DynamicsMarket DriversMarket RestraintsMarket OpportunitiesKey InsightsPrevalence of Major Disorders Associated with Exocrine Pancreatic InsufficiencyPipeline AnalysisRecent Industry Developments Such as Mergers, Partnerships & AcquisitionsRegulatory ScenarioNew Product LaunchesContinuous…
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com
0